Mitigating the risk of viral contamination in vaccines, cell, and gene therapies.
Examine the options available for measuring your laboratory capacity.
Experts share their unique perspectives on the various technologies to prevent, detect, and remove virus contamination.
Multilayered approach includes virus-resistant CHO cell lines, advanced filtration technologies, and careful raw material selection.
The wide range of antibody fragment variants for which Amsphere A3 can be used as a capture resin is described, together with insight to the related binding mechanisms obtained via x-ray crystallography.
How a proactive approach involving predictive — rather than preventive — tools to identify deficiencies before they compound and become actual problems can result in a healthy bioprocessing facility.
How can end users ensure the expected level of compliance in this new world of single-use systems? The secret: shared responsibility for validation with your supply chain.
This white paper addresses the challenges associated with the bioburden control process involved in making mAbs or other biologicals, as well as the single-use solutions and improved ways of working that manufacturers can use to avoid microbial contamination.
A discussion on the risks related to bioburden downstream processing and ways to mitigate them. Topics covered include improvements in raw material, equipment design, and chromatography resin properties.
The reality is that several manufacturability problems could be brewing that will rain down during Phase III and cause costly delays, no matter how skilled the product and process may be.
|
|
|
|
|
|
|
|
|